
zzso zzso zzso is a common cancer with poor prognosis and worldwide rising zzso during the last zzso Although zzso liver zzso surgical zzso and local destruction zzso or zzso acid and zzso zzso are the only zzso approaches, this can be accomplished in a minority of patients, since most of them present with advanced zzso In addition, those patients who have undergone zzso treatment experience a high tumor recurrence zzso zzso zzso is associated with a poor prognosis due to wide resistance to zzso zzso It is therefore essential to search for new zzso zzso After several years of zzso research, the first clinical study data on molecular targeting therapy are now available for this tumor zzso zzso of the zzso growth factor zzso zzso family, such as zzso and zzso were recently zzso Furthermore, zzso an inhibitor of vascular zzso growth factor zzso zzso a multiple zzso inhibitor that blocks several zzso zzso zzso and zzso zzso zzso a multiple zzso inhibitor that blocks not only zzso zzso zzso but also zzso zzso along the zzso pathway, were zzso as zzso Until now, the only agent that has to be proven to be effective in terms of survival outcome in two phase III zzso studies is zzso which became the current standard for zzso zzso 

